Research Group
Cancer Biomarkers
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT00095589
RATIONALE: New diagnostic procedures such as microsatellite analysis of sediment in the urine may improve the ability to detect bladder cancer without invasive procedures.
PURPOSE: Diagnostic trial to study the effectiveness of microsatellite analysis of sediment in the urine in detecting bladder cancer in healthy participants, participants who have genitourinary conditions requiring cystoscopy, and patients who have bladder cancer.
PURPOSE: Diagnostic trial to study the effectiveness of microsatellite analysis of sediment in the urine in detecting bladder cancer in healthy participants, participants who have genitourinary conditions requiring cystoscopy, and patients who have bladder cancer.
Intervention
computed tomography, cystoscopy, cytology specimen collection procedure, laboratory biomarker analysis, loss of heterozygosity analysis, microarray analysis, microsatellite instability analysis
Condition
Bladder Cancer
Investigators
Mark P. Schoenberg, MD